Genencor

Genencor International
TypePrivate
IndustryBiotechnology
Founded1982
HeadquartersPalo Alto, California, United States,
Key people
Tjerk de Ruiter, Chairman & CEO
Michael Arbige, Vice President, Technology
Jim Sjoerdsma, Sr. Vice President, Human Resources
David Estell, Vice President, innovation
ProductsPurafect, Properase, Spezyme
RevenueIncrease $380 Million USD (2005)
Number of employees
1,500 (2005)
ParentDuPont
Websitehttp://biosciences.dupont.com//

[1]Genencor is a biotechnology company based in Palo Alto, CA and a subsidiary of DuPont. Genencor is a leading producer of Industrial enzymes and low-priced bulk protein. The name Genencor originates with Genencor, Inc., the original joint venture between Genentech and Corning Incorporated, which was founded in 1982. It is considered to have pioneered the field of industrial biotechnology, as distinct from traditional applications of biotechnology to health care and agriculture.

In 2005 Genencor was acquired by Danisco.[2]

In 2008 Genencor entered a joint venture with DuPont, called DuPont Danisco Cellulosic Ethanol LLC, to develop and commercialize low cost technology for the production of cellulosic ethanol. In 2008, Genencor and Goodyear announced they were working to develop BioIsoprene.

In 2011, Dupont acquired [1]Danisco for $6.3 billion.

In 2021, portions of Dupont including the Genencor division were acquired by International Flavors & Fragrances.

Awards

Genencor achieved the following awards:

  • Named No. 2 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2004)
  • Named No. 1 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2005)
  • Named No. 1 Best Place to Work in the Bay Area by the San Francisco Chronicle (2005)
  • Named No. 11 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2011)

See also

References

  1. ^ a b DuPont. "DuPont to Acquire Danisco for $6.3 Billion". www.prnewswire.com. Retrieved 2019-07-11.
  2. ^ Danisco acquire Genencor for $419 million


This article is copied from an article on Wikipedia® - the free encyclopedia created and edited by its online user community. The text was not checked or edited by anyone on our staff. Although the vast majority of Wikipedia® encyclopedia articles provide accurate and timely information, please do not assume the accuracy of any particular article. This article is distributed under the terms of GNU Free Documentation License.